全文获取类型
收费全文 | 5456篇 |
免费 | 413篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 142篇 |
妇产科学 | 102篇 |
基础医学 | 676篇 |
口腔科学 | 47篇 |
临床医学 | 663篇 |
内科学 | 1000篇 |
皮肤病学 | 90篇 |
神经病学 | 858篇 |
特种医学 | 404篇 |
外科学 | 838篇 |
综合类 | 70篇 |
一般理论 | 1篇 |
预防医学 | 269篇 |
眼科学 | 93篇 |
药学 | 342篇 |
中国医学 | 4篇 |
肿瘤学 | 269篇 |
出版年
2021年 | 53篇 |
2020年 | 41篇 |
2019年 | 57篇 |
2018年 | 77篇 |
2017年 | 66篇 |
2016年 | 83篇 |
2015年 | 96篇 |
2014年 | 108篇 |
2013年 | 137篇 |
2012年 | 217篇 |
2011年 | 200篇 |
2010年 | 140篇 |
2009年 | 158篇 |
2008年 | 228篇 |
2007年 | 261篇 |
2006年 | 230篇 |
2005年 | 258篇 |
2004年 | 213篇 |
2003年 | 239篇 |
2002年 | 229篇 |
2001年 | 218篇 |
2000年 | 189篇 |
1999年 | 159篇 |
1998年 | 67篇 |
1997年 | 58篇 |
1996年 | 61篇 |
1995年 | 73篇 |
1994年 | 52篇 |
1993年 | 61篇 |
1992年 | 104篇 |
1991年 | 105篇 |
1990年 | 110篇 |
1989年 | 120篇 |
1988年 | 105篇 |
1987年 | 106篇 |
1986年 | 98篇 |
1985年 | 129篇 |
1984年 | 81篇 |
1983年 | 67篇 |
1982年 | 46篇 |
1981年 | 47篇 |
1980年 | 39篇 |
1979年 | 77篇 |
1978年 | 50篇 |
1977年 | 59篇 |
1976年 | 49篇 |
1975年 | 37篇 |
1974年 | 57篇 |
1973年 | 49篇 |
1972年 | 38篇 |
排序方式: 共有5897条查询结果,搜索用时 15 毫秒
91.
92.
A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D 总被引:2,自引:0,他引:2
Cruz PE Khalil PL Dryden TD Chiou HC Fink PS Berberich SJ Bigley NJ 《Vaccine》1999,17(9-10):1091-1099
DNA molecules complexed with an asialoglycoprotein-polycation conjugate, consisting of asialoorosomucoid (ASOR) coupled to poly-L-lysine, can enter hepatocytes which bear receptors for ASOR. We used this receptor-mediated DNA delivery system to deliver plasmid DNA encoding glycoprotein D (gD) of herpes simplex virus type 1 to ASOR-positive cells. Maximum expression of gD protein was seen at 3 days after injection of this preparation in approximately 13% of cells from BALB/c mice [hepatocytes from mice injected intravenously (i.v.) or peritoneal exudate cells from mice injected intraperitoneally (i.p.)]. In comparison with mice injected with either the plasmid vector alone or the gD-containing plasmid uncomplexed to ASOR, mice immunized with gD-containing plasmid complexed with ASOR-poly-L-lysine induced marked antigen-specific CTL responses. BALB/c mice immunized with gD-DNA developed a T-cell-mediated CTL response against target cells expressing gD and MHC class II glycoproteins, but not against cells expressing only gD and MHC class I molecules. In C3H mice, gD-DNA induced a T-cell-mediated CTL response against target cells expressing gD and class I MHC molecules. Serum anti-gD antibody in low titers were produced in both strains of mice. DNA complexed with ASOR-poly-L-lysine induced CTL responses in mice. 相似文献
93.
In an open clinical trial, depressed patients received age-dosed, brief-pulse electroconvulsive therapy (ECT) either with or without 500 mg i.v. caffeine sodium benzoate before each treatment. Caffeine-pretreated patients required fewer ECT treatments, and after three to four treatments, their Hamilton Depression Scale (HDS) scores were significantly lower. At the end of the ECT course, both groups reached the same reduction in HDS scores. Of five memory tests, one showed better performance at the end of the ECT course for the caffeine-pretreated compared with the non-caffeine-pretreated patients. The results argue that caffeine-modified ECT differs from unmodified ECT in speed of response and the effects on cognitive tests. 相似文献
94.
The diagnostic separation of the reversible dementia of an affective disorder from the dementia secondary to structural brain pathology remains a clinical challenge. A 58-year-old woman had been diagnosed as having Alzheimer's dementia for 9 years before antidepressant treatment with electroconvulsive therapy (ECT) resolved the dementia syndrome. The patient has functioned well for 8 years on maintenance treatment with lithium, with ECT given every 7-8 weeks. By the summer of 1993, she had undergone 132 ECT. Until specific and reliable pre-morbid tests for the diagnosis of irreversible dementias of the Alzheimer's and multiinfarct types are developed, antidepressant treatment trials are encouraged in elderly patients with a dementia syndrome. Extensive maintenance ECT schedules are safe. 相似文献
95.
96.
97.
98.
99.
D Fink 《Psychiatric Clinics of North America》1991,14(3):547-566
Our ability to differentiate MPD from DSM-III-R Axis I disorders has become increasingly refined. Differentiation of MPD from the Axis II personality disorders is an area of more recent clinical investigation. MPD can be found comorbidity with many other psychiatric conditions. It is found in association with each of the DSM-III-R personality disorders. At the present time, however, we lack research data that define the prevalence of the comorbidity of MPD with the personality disorders. Objective study of this area is complicated by the paucity of instruments available to assess personality dimensions in the presence of a DD. In addition, the currently available personality inventories tend to overdiagnose BPD in patients with a high level of distress and acuity of symptoms. The diagnosis of a personality disorder in a patient with MPD is made on the basis of the assessment of the "whole" human being. It is based on the presence of a pervasive and relatively inflexible pattern of behaviors that reflects the individual predominant mode of being. The diagnosis of a personality disorder is not made on the basis of personality traits contained within any single alternate personality or groups of personalities. The personality disorders defined by DSM-III-R are a heterogeneous group of conditions whose individual etiologies reflect a complex interplay of constitutional, genetic, environmental, interpersonal, and psychodynamic factors. The interplay is variable and diverse between these determinants of the personality disorders and the traumatic forces that result in the development of a DD. For the Cluster A personality disorders (schizoid, schizotypal, paranoid), there is evidence supporting a relationship with specific psychotic illnesses. The combination of dissociative pathology with these personality disorders commonly results in a greater impairment of reality testing than in either condition alone. The Cluster B personality disorders (histrionic, narcissistic, borderline, antisocial) and Cluster C personality disorders (avoidant, compulsive, dependent, passive-aggressive) are believed to be primarily developmental disturbances. Comorbidity of these personality disorders with MPD involves consideration of the interaction of many developmental processes with the psychological impact of severe childhood trauma. Many MPD patients present with an apparent mixed personality profile consisting of an array of avoidant, compulsive, borderline, narcissistic, dependent, and passive-aggressive features. Although this article explores comorbidity of MPD with each of the personality disorders defined in DSM-III-R individually, it seems likely that a number of posttraumatic personality organizations can be defined that commonly coexist with MPD.(ABSTRACT TRUNCATED AT 400 WORDS) 相似文献
100.
J. Lammer R. Nicoletti G. F. Fueger W. Fink 《European journal of nuclear medicine and molecular imaging》1982,7(8):364-369
A computer macro-program was developed for standardized, semiquantitative measurement of ossal radiotracer uptake. The method uses profiles of selectable length, width, and inclination according to the anatomical structures of the pathological and the corresponding healthy region. The ratio of the two curves is calculated automatically and shown as an uptake curve. The essential use of osteoscintimetry is in the follow-up examination if small changes of regional uptake have to be identified. The profile-technique rather than the ROI-technique was selected, because the main benefit of the profile-technique is that the results of follow-up examinations are comparable to previous examinations with a standard deviation of ±5%. 相似文献